You are here

Article info

Article menu
Download PDFPDF
Cystic fibrosis
Original research
Longitudinal effects of ivacaftor and medicine possession ratio in people with the Gly551Asp mutation: a 5-year study

Authors

  • Ruth Marian Mitchell Manchester Adult Cystic Fibrosis Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Andrew M Jones Manchester Adult Cystic Fibrosis Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • Katie Stocking Centre for Biostatistics, Division of Population Health, Health Services Research and Primary Care, The University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • Philip Foden Department of Medical Statistics, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Peter J Barry Manchester Adult Cystic Fibrosis Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Peter J Barry, Manchester Adult Cystic Fibrosis Centre, Manchester University NHS Foundation Trust, Manchester, UK; peter.barry{at}mft.nhs.uk
View Full Text

Citation

Mitchell RM, Jones AM, Stocking K, et al
Longitudinal effects of ivacaftor and medicine possession ratio in people with the Gly551Asp mutation: a 5-year study
Thorax 2021;76:874-879.

Publication history

  • Received June 17, 2020
  • Revised December 28, 2020
  • Accepted January 19, 2021
  • First published February 12, 2021.
Online issue publication 
February 19, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.